Tower Research Capital LLC (Trc) Evoke Pharma Inc Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.43 - $0.62 $31 - $45	74 Added 1.0%	7,479 $3,000
Q1 2024 May 15, 2024	BUY	$0.59 - $1.07 $565 - $1,026	959 Added 14.88%	7,405 $4,000
Q4 2023 Feb 13, 2024	BUY	$1.05 - $1.39 $685 - $907	653 Added 11.27%	6,446 $6,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.73 $204 - $368	213 Added 3.82%	5,793 $7,000
Q2 2023 Aug 14, 2023	BUY	$1.39 - $2.25 $2,217 - $3,588	1,595 Added 40.03%	5,580 $9,000
Q1 2023 May 09, 2023	BUY	$1.89 - $5.75 $5,919 - $18,009	3,132 Added 367.17%	3,985 $8,000
Q4 2022 Feb 10, 2023	SELL	$1.44 - $2.68 $2,008 - $3,738	-1,395 Reduced 62.06%	853 $2,000
Q3 2022 Nov 10, 2022	SELL	$1.95 - $3.43 $302 - $531	-155 Reduced 6.45%	2,248 $4,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $10.32 $4,902 - $24,798	2,403 New	2,403 $8,000

1.46K

Ticker EVOK
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,343,070
Market Cap $1.57M
Description
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.